| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman | CEO &President | Director
2 companies
Leiden Jeffrey M is an Executive Chairman at VERTEX PHARMACEUTICALS INC / MA with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $12.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sale+OE | 9,434 | $210.00 | $1,981,140.00 | -2.2% | |
| Nov 1, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sale+OE | 105,701 | $200.02 | $21,141,791.92 | -24.9% | |
| Oct 22, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sale+OE | 107,831 | $190.00 | $20,487,890.00 | -33.7% | |
| Jun 18, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sale+OE | 56,030 | $175.39 | $9,827,054.12 | -20.5% | |
| May 24, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sale+OE | 113,432 | $175.10 | $19,861,943.20 | -51.6% | |
| May 29, 2018 | DGX Quest Diagnostics Inc | Director | Sell | 1,644 | $105.61 | $173,622.84 | -21.5% | |
| Aug 4, 2017 | DGX Quest Diagnostics Inc | Director | Sell | 296 | $106.66 | $31,571.06 | -4.7% | |
| Jul 27, 2017 | DGX Quest Diagnostics Inc | Director | Sell | 1,304 | $108.73 | $141,782.62 | -17.2% | |
| Aug 3, 2016 | DGX Quest Diagnostics Inc | Director | Sale+OE | 6,345 | $85.62 | $543,262.48 | -14.7% |